Clinical Trial Update: Oral Propanolol for Surgically Inaccessible Cavernous Malformations [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating oral propranolol for cavernous malformations of the brain and/or spinal cord, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Cavernous Malformations
• Spinal Cavernous Malformations

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: University of Virginia | Conditions: Cavernous Malformations,Cerebral and/or Spinal | Phase 1 | Status: UNKNOWN